Evidence map›Paper›PMID 32037861›Full record

Trial reportClinical rehabilitation2020

Phase I randomized single-blinded controlled study investigating the potential benefit of aerobic exercise in degenerative cerebellar disease.

Scott Barbuto, Dario Martelli, Isarime Babajide Omofuma, Nancy Lee, Sheng-Han Kuo, Sunil Agrawal, Seonjoo Lee, Michael O'Dell, Joel Stein

Open access · greenAbstract readClinical Trial, Phase IIRandomized Controlled Trial
In one paragraph

Trial report in Clinical rehabilitation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Changes in Gait After Training for Individuals With Cerebellar Ataxia.Archives of rehabilitation research and clinical translation · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Observational
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Scott BarbutoDepartment of Physical Medicine and Rehabilitation, Vagelos College of Physicians and Surgeons, Columbia University Medical Center, New York, NY, USA.ORCID https://orcid.org/0000-0001-9494-9708
Dario MartelliDepartment of Mechanical Engineering, Columbia University, New York, NY, USA.
Isarime Babajide OmofumaDepartment of Mechanical Engineering, Columbia University, New York, NY, USA.
Nancy LeeDepartment of Physical Medicine and Rehabilitation, Vagelos College of Physicians and Surgeons, Columbia University Medical Center, New York, NY, USA.
Sheng-Han KuoDepartment of Neurology, Vagelos College of Physicians and Surgeons, Columbia University Medical Center, New York, NY, USA.
Sunil AgrawalDepartment of Mechanical Engineering, Columbia University, New York, NY, USA.
Seonjoo LeeDepartment of Biostatistics, Vagelos College of Physicians and Surgeons, Columbia University Medical Center, New York, NY, USA.
Michael O'DellDepartment of Rehabilitation Medicine, Weill Cornell Medical College, Cornell University, New York, NY, USA.
Joel SteinDepartment of Rehabilitation Medicine, Weill Cornell Medical College, Cornell University, New York, NY, USA.
Columbia University Irving Medical Center · USColumbia University · USCornell University · US

Funding

Targeting Cerebellar Excitatory Synapses for Tremor ProgressionR01NS118179 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KUO, SHENG-HAN · 2020 to 2024
$2.2M
Cerebellar Circuitry in the Pathophysiology of TremorR01NS104423 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KUO, SHENG-HAN · 2018 to 2022
$2.0M
NINDS NIH HHS R01 NS104423NINDS NIH HHS R01 NS118179
6 · The paper itself

Abstract

objectivesTo investigate whether people with cerebellar degeneration can perform rigorous aerobic exercise and to assess the clinical impact of training.

designRandomized single-blinded controlled, feasibility study comparing aerobic training to no training.

settingHome intervention, assessments conducted at an academic medical center. SUBJECTS: Twenty individuals with cerebellar degeneration caused by a range of genetic disorders.

interventionAerobic training consisted of four weeks of stationary bicycle training, five times per week for 30-minute sessions. Intensity ranged from 65% to 80% of the participant's maximal heart rate determined during cardiopulmonary exercise testing. MAIN MEASURES: Primary outcome measure was change in the Scale for the Assessment and Rating of Ataxia scores. Recruitment rate, adherence, drop-out, and adverse events were also determined. The treatment was considered technically feasible if participants achieved target training frequency, duration, and intensity.

resultsThe 20 participants mean age was 50 years (standard deviation 15.65 years) and average Scale for the Assessment and Rating of Ataxia score was 9.6 (standard deviation 3.13). Ten participants were randomized to aerobic training and 10 to no training. Seven participants in the aerobic group attained target training duration, frequency, and intensity. There was a mean reduction in ataxia severity of 2.1 points (standard deviation 1.26) with four weeks of aerobic training, whereas ataxia severity increased by 0.3 (standard deviation 0.62) in the control group over the same period. Walking speed, balance measures, and fitness also improved in individuals who performed aerobic exercise.

conclusionsRigorous aerobic training is feasible in people with cerebellar degeneration. Improvements in ataxia, balance, and gait are promising.

Indexed as

ExerciseExercise TherapyAdultAgedCerebellar DiseasesExercise TestFeasibility StudiesFemaleHumansMaleMiddle AgedPostural BalanceSingle-Blind MethodTreatment OutcomeWalking Speedaerobic exerciseAtaxiarehabilitationspinocerebellar degenerationtreatment outcome

Identifiers

PMID32037861
PMCPMC7311185
OpenAlexW3006493579

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.